CSNpharm
Bromfenac Sodium is a nonsteroidal anti-inflammatory drug (NSAID), which has anti-inflammatory activity and may block prostaglandin synthesis by inhibiting cyclooxygenase 1 and 2.
More Information
Supplier Page
CSNpharm
CSNpharm
Bromobimane, a thiol-reactive fluorogenic probe, is nonfluorescent molecule which can react with small thiols and reactive protein thiol groups.
More Information
Supplier Page
CSNpharm
Bromobimane, a thiol-reactive fluorogenic probe, is nonfluorescent molecule which can react with small thiols and reactive protein thiol groups.
More Information
Supplier Page
CSNpharm
Bromocriptine mesylate is a potent dopamine D2/D3 receptoragonist, which binds D2 dopamine receptor with pKi of 8.05±0.2.
More Information
Supplier Page
CSNpharm
Bromocriptine mesylate is a potent dopamine D2/D3 receptoragonist, which binds D2 dopamine receptor with pKi of 8.05±0.2.
More Information
Supplier Page
CSNpharm
Bromocriptine mesylate is a potent dopamine D2/D3 receptoragonist, which binds D2 dopamine receptor with pKi of 8.05±0.2.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Bropirimine is a synthetic agonist for toll-like receptor 7 (TLR7). Bropirimine inhibits differentiation of osteoclast precursor cells into osteoclasts via TLR7-mediated production of IFN-β. Bropirimine is an orally active immunomodulator that has demonstrated anticancer activity in transitional cell carcinoma in situ (CIS) in both the bladder and upper urinary tract[1][2].
More Information
Supplier Page
CSNpharm
Broussonin A, a natural product isolated and purified from the branch of Broussonetia papyrifera, has suppressive effects on iNOS expression might provide one possible mechanism for the anti-inflammatory activity.
More Information
Supplier Page
CSNpharm
Broussonin A, a natural product isolated and purified from the branch of Broussonetia papyrifera, has suppressive effects on iNOS expression might provide one possible mechanism for the anti-inflammatory activity.
More Information
Supplier Page
CSNpharm
Broussonin B, a natural product isolated and purified from the branch of Broussonetia papyrifera, induces neurite outgrowth in PC-12 cells at concentration of 50 mg/mL and shows moderate inhibitory activities against a chymotrypsin-like activity of the proteasome.
More Information
Supplier Page
CSNpharm
Broussonin B, a natural product isolated and purified from the branch of Broussonetia papyrifera, induces neurite outgrowth in PC-12 cells at concentration of 50 mg/mL and shows moderate inhibitory activities against a chymotrypsin-like activity of the proteasome.
More Information
Supplier Page
CSNpharm
Broussonin C, a natural product isolated and purified from the branch of Broussonetia papyrifera, exerts simple reversible slow-binding inhibition against diphenolase.
More Information
Supplier Page
CSNpharm
Broussonin C, a natural product isolated and purified from the branch of Broussonetia papyrifera, exerts simple reversible slow-binding inhibition against diphenolase.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
Broxyquinoline is an antiprotozoal agent and able to release oxygen free radicals from the water in mucous membranes.
More Information
Supplier Page
CSNpharm
Broxyquinoline is an antiprotozoal agent and able to release oxygen free radicals from the water in mucous membranes.
More Information
Supplier Page
CSNpharm
Brr2 inhibitor C9 is an allosteric inhibitor targeting the spliceosomal RNA helicase Brr2, which implicated in autosomal-dominant retinitis pigmentosa, a group of progressive retinal degenerative disorders.
More Information
Supplier Page
CSNpharm
Brr2 inhibitor C9 is an allosteric inhibitor targeting the spliceosomal RNA helicase Brr2, which implicated in autosomal-dominant retinitis pigmentosa, a group of progressive retinal degenerative disorders.
More Information
Supplier Page
CSNpharm
Brr2 inhibitor C9 is an allosteric inhibitor targeting the spliceosomal RNA helicase Brr2, which implicated in autosomal-dominant retinitis pigmentosa, a group of progressive retinal degenerative disorders.
More Information
Supplier Page
CSNpharm
Brr2 inhibitor C9 is an allosteric inhibitor targeting the spliceosomal RNA helicase Brr2, which implicated in autosomal-dominant retinitis pigmentosa, a group of progressive retinal degenerative disorders.
More Information
Supplier Page
CSNpharm
Brr2 inhibitor C9 is an allosteric inhibitor targeting the spliceosomal RNA helicase Brr2, which implicated in autosomal-dominant retinitis pigmentosa, a group of progressive retinal degenerative disorders.
More Information
Supplier Page
CSNpharm
Brr2 inhibitor C9 is an allosteric inhibitor targeting the spliceosomal RNA helicase Brr2, which implicated in autosomal-dominant retinitis pigmentosa, a group of progressive retinal degenerative disorders.
More Information
Supplier Page
CSNpharm
Bruceine D, a natural product isolated and purified from the barks of Ailanthus altissima, may have the potential to be used as a natural viricide, or a lead compound for viricides, inhibits the growth of three pancreatic cancer cell lines, i.e., PANC-1, SW1990 and CAPAN-1, and induces cytotoxicity in Capan-2 cells via the induction of […]
More Information
Supplier Page
CSNpharm
Bruceine D, a natural product isolated and purified from the barks of Ailanthus altissima, may have the potential to be used as a natural viricide, or a lead compound for viricides, inhibits the growth of three pancreatic cancer cell lines, i.e., PANC-1, SW1990 and CAPAN-1, and induces cytotoxicity in Capan-2 cells via the induction of […]
More Information
Supplier Page
CSNpharm
Bruceine D, a natural product isolated and purified from the barks of Ailanthus altissima, may have the potential to be used as a natural viricide, or a lead compound for viricides, inhibits the growth of three pancreatic cancer cell lines, i.e., PANC-1, SW1990 and CAPAN-1, and induces cytotoxicity in Capan-2 cells via the induction of […]
More Information
Supplier Page
CSNpharm
Bruceine D, a natural product isolated and purified from the barks of Ailanthus altissima, may have the potential to be used as a natural viricide, or a lead compound for viricides, inhibits the growth of three pancreatic cancer cell lines, i.e., PANC-1, SW1990 and CAPAN-1, and induces cytotoxicity in Capan-2 cells via the induction of […]
More Information
Supplier Page
CSNpharm
Brusatol is a plant-derived natural quassinoid that exhibits broad cytotoxicity in cancer cultures (IC50 < 1 μM against 457 cancer cell lines) by inhibiting de novo synthesis of cellular proteins (Effective conc. < 50 nM in A549 cells), including NRF2.
More Information
Supplier Page
CSNpharm
Brusatol is a plant-derived natural quassinoid that exhibits broad cytotoxicity in cancer cultures (IC50 < 1 μM against 457 cancer cell lines) by inhibiting de novo synthesis of cellular proteins (Effective conc. < 50 nM in A549 cells), including NRF2.
More Information
Supplier Page
CSNpharm
Brusatol is a plant-derived natural quassinoid that exhibits broad cytotoxicity in cancer cultures (IC50 < 1 μM against 457 cancer cell lines) by inhibiting de novo synthesis of cellular proteins (Effective conc. < 50 nM in A549 cells), including NRF2.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
BT2
100mg
| ≥97%
CSNpharm
BT2 is a BCKDC kinase (BDK) inhibitor with an IC50 of 3.19 μM. BT2 binding to BDK triggers helix movements in the N-terminal domain, resulting in the dissociation of BDK from the branched-chain α-ketoacid dehydrogenase complex (BCKDC). BT2 (compound 4) is also a potent and selective Mcl-1 inhibitor with a Ki value of 59 μM.
More Information
Supplier Page
BTB1
10mg
| ≥99%
CSNpharm
BTB1
5mg
| ≥99%
CSNpharm
